ID

31190

Beschreibung

Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00995761

Link

https://clinicaltrials.gov/show/NCT00995761

Stichworte

Versionen (1)
  1. 26.07.18 26.07.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

26. Juli 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Non-small Cell Lung Cancer NCT00995761

Englisch

Eligibility Non-small Cell Lung Cancer NCT00995761

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who were≥ 65 years of age and they had an easten cooperative oncology group (ecog) performance status (ps) of 0-2, or the patients who were < 65 years of age and they had an ecog ps 2
Beschreibung

Age | ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C1520224
histologically confirmed non-small cell carcinoma
Beschreibung

Non-small cell carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C1266002
stages iiib-iv disease
Beschreibung

Disease TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
adequate hematologic parameters (hemoglobin concentration of at least 9.0 g/dl, absolute neutrophil count ≥1,500/mm3, and platelet count ≥100,000/mm3), renal function (serum creatinine ≤1.5 mg/dl), and liver function (total bilirubin ≤1.5 mg/dl and serum transaminase level less than twice the upper limit of normal)
Beschreibung

Parameters Hematologic | Hemoglobin measurement | Absolute neutrophil count | Platelet Count measurement | Renal function | Creatinine measurement, serum | Liver function | Serum total bilirubin measurement | Transaminase Assay

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0449381
UMLS CUI [1,2]
C0205488
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0948762
UMLS CUI [4]
C0032181
UMLS CUI [5]
C0232804
UMLS CUI [6]
C0201976
UMLS CUI [7]
C0232741
UMLS CUI [8]
C1278039
UMLS CUI [9]
C0919834
at least one bi-dimensionally measurable lesion, according to the response evaluation criteria in solid tumors (recist) version 1.1
Beschreibung

Measurable lesion 2-Dimensional Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
UMLS CUI [1,3]
C1265611
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
active infection
Beschreibung

Communicable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
prior chemotherapy, radiotherapy or surgery for their disease,
Beschreibung

Prior Chemotherapy Disease | Prior radiation therapy Disease | Operative Surgical Procedures Previous Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0012634
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0012634
UMLS CUI [3,1]
C0543467
UMLS CUI [3,2]
C0205156
UMLS CUI [3,3]
C0012634
a history of myocardial infarction in the last 3 months before entry to the study
Beschreibung

Myocardial Infarction

Datentyp

boolean

Alias
UMLS CUI [1]
C0027051
uncontrolled congestive heart failure or hypertension
Beschreibung

Congestive heart failure Uncontrolled | Uncontrolled hypertension

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C1868885
uncontrolled diabetes mellitus, pregnancy, lactation or a prior second primary cancer except for cervix cancer in situ or skin cancer
Beschreibung

Diabetic - poor control | Pregnancy | Breast Feeding | Second Primary Cancers | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0421258
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0751623
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0851140
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0699893
all the patients provided written informed consent before they entered the study
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Non-small Cell Lung Cancer NCT00995761

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | ECOG performance status
Item
patients who were≥ 65 years of age and they had an easten cooperative oncology group (ecog) performance status (ps) of 0-2, or the patients who were < 65 years of age and they had an ecog ps 2
boolean
C0001779 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
Non-small cell carcinoma
Item
histologically confirmed non-small cell carcinoma
boolean
C1266002 (UMLS CUI [1])
Disease TNM clinical staging
Item
stages iiib-iv disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Parameters Hematologic | Hemoglobin measurement | Absolute neutrophil count | Platelet Count measurement | Renal function | Creatinine measurement, serum | Liver function | Serum total bilirubin measurement | Transaminase Assay
Item
adequate hematologic parameters (hemoglobin concentration of at least 9.0 g/dl, absolute neutrophil count ≥1,500/mm3, and platelet count ≥100,000/mm3), renal function (serum creatinine ≤1.5 mg/dl), and liver function (total bilirubin ≤1.5 mg/dl and serum transaminase level less than twice the upper limit of normal)
boolean
C0449381 (UMLS CUI [1,1])
C0205488 (UMLS CUI [1,2])
C0518015 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0232804 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
C0232741 (UMLS CUI [7])
C1278039 (UMLS CUI [8])
C0919834 (UMLS CUI [9])
Measurable lesion 2-Dimensional Quantity
Item
at least one bi-dimensionally measurable lesion, according to the response evaluation criteria in solid tumors (recist) version 1.1
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Prior Chemotherapy Disease | Prior radiation therapy Disease | Operative Surgical Procedures Previous Disease
Item
prior chemotherapy, radiotherapy or surgery for their disease,
boolean
C1514457 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0543467 (UMLS CUI [3,1])
C0205156 (UMLS CUI [3,2])
C0012634 (UMLS CUI [3,3])
Myocardial Infarction
Item
a history of myocardial infarction in the last 3 months before entry to the study
boolean
C0027051 (UMLS CUI [1])
Congestive heart failure Uncontrolled | Uncontrolled hypertension
Item
uncontrolled congestive heart failure or hypertension
boolean
C0018802 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2])
Diabetic - poor control | Pregnancy | Breast Feeding | Second Primary Cancers | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma
Item
uncontrolled diabetes mellitus, pregnancy, lactation or a prior second primary cancer except for cervix cancer in situ or skin cancer
boolean
C0421258 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0751623 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C0851140 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0699893 (UMLS CUI [6,2])
Informed Consent
Item
all the patients provided written informed consent before they entered the study
boolean
C0021430 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video